A recently released Cambridge University study offered hope for those suffering from the ill effects of MS, multiple sclerosis, which is a degenerative muscular disorder. The study showed that through stem cell and remyelination therapy could be beneficial in restoring the damaged nerves throughout the body, even in sufferers of MS at more advanced ages.
Professor Robin Franklin, director of the MS Society’s Cambridge Centre for Myelin Repair at the university, said: “What we have shown in our study, carried out in collaboration with Dr Amy Wagers and colleagues at Harvard University, is that the age-associated decline in remyelination is reversible. We found that remyelination in old adult mice can be made to work as efficiently as it does in young adult mice.
“For individuals with MS, this means that in theory regenerative therapies will work throughout the duration of the disease. Specifically, it means that remyelination therapies do not need to be based on stem cell transplantation since the stem cells already present in the brain and spinal cord can be made to regenerate myelin – regardless of the patient’s age.”
This is a fascinating find, as it gives hope to MS patients that bringing back nerve feeling and reversing damage is possible, and thus some of the side effects of MS can be alleviated. Though still in the clinical study and trial phase, this research holds promise for advancements in the field of MS.